parecoxib
Sign in to saveParecoxib, sold under the brand name Dynastat among others, is a water-soluble and injectable prodrug of valdecoxib. Parecoxib is a COX2 selective inhibitor. It is injectable. It is approved in the European Union for short term perioperative pain control.
Research
769 papers- Parecoxib sequential with imrecoxib for occurrence and remission of severe acute pancreatitis: a multicentre, double-blind, randomised, placebo-controlled trial.Gut · 2025
- Parecoxib: a shift in pain management?Expert review of neurotherapeutics · 2004
- Intravenous parecoxib for early postoperative cognitive dysfunction in elderly patients: evidence from a meta-analysis.Expert review of clinical pharmacology · 2020
- Efficacy of parecoxib sodium on postoperative shivering: meta-analysis of clinical trials.The Journal of international medical research · 2018
- Parecoxib (parecoxib sodium).Drugs · 2001
via PubMed
~4 min read
Encyclopedic overview
3 sectionsContents
- Approval
- References
- Further reading
{{Drugbox | Verifiedfields = changed | verifiedrevid = 464197422 | image = Parecoxib.svg | image_class = skin-invert-image
| pronounce = | tradename = | Drugs.com = | MedlinePlus = | DailyMedID = | pregnancy_AU = C | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = Intravenous, intramuscular | class = | ATC_prefix = M01 | ATC_suffix = AH04 | ATC_supplemental =
Excerpted from Wikipedia’s “parecoxib” article, available under the CC BY-SA 4.0 licence.
Available in 16 languages
- Français
- Deutsch
- Русский
- Italiano
- العربية
- Bahasa Indonesia
- Nederlands
- Romanian
- Serbian
- Serbian (Latin)
- Slovak
- Svenska
- Ukrainian
- فارسی
- ไทย
via Wikidata sitelinks · CC0